Human rhinovirus 3C protease inhibitors: recent developments

Bibliography

• COUCH RB: Rhinoviruses. In: Virology. Fields BN, Knipe DM (Eds.), Raven Press, New York (1990):607–629.
   Google Scholar
• PALMENBERG AC: Proteolytic procession of picornavi-ral polyprotein. Ann. Rev. Microbic)]. (1990) 44:603–623.
   PubMed Web of Science ®Google Scholar
• PORTER AG: Picornavirus nonstructural proteins:emerging roles in virus replication and inhibition of host cell functions. J. Virol (1993) 67:6917–6921.
   PubMed Web of Science ®Google Scholar
• CLARK ME, HAMMERLE T, WIMMER E, DASGUPTA A: Po-liovirus proteinase 3C converts an active form of tran-scription factor MC to an inactive form: a mechanism for inhibition of host cell polymerase III transcription by poliovirus. EMBO J (1991) 10:2941–2947.
   PubMedGoogle Scholar
• MATTHEWS DA, SMITH WA, FERRE RA et al.: Structure ofhuman rhinovirus 3C protease reveals a trypsin-like polypeptide fold, RNA-binding site, and means for cleaving precursor polyprotein. Cell (1994) 77:761–771.
   PubMed Web of Science ®Google Scholar
• •Crystal structure of the HRV 3C protease.
   Google Scholar
• CORDINGLEY MG, CALLAHAN PL, SARDANA W, GARSKY VM, COLONNO RJ: Substrate requirements of human rhinovirus 3C protease for peptide cleavage in vitro. J. Biol. Chem. (1990) 265:9062–9065.
   PubMed Web of Science ®Google Scholar
• •Substrate specificity studies of the 3C protease. The informa-tion provided in this paper is important for rational design of 3C protease inhibitors.
   Google Scholar
• ORR DC, LONG AC, KAY J, DUNN BM, CAMERON JM: Hy- drolysis of a series of synthetic peptide substrates by the human rhinovirus 14 3C proteinase, cloned and expressed in Escherichia coli. J. Gen. Virol. (1989) 70:2931–2942.
   Google Scholar
• •Substrate specificity studies of the 3C protease. The informa-tion provided in this paper is important for rational design of 3C protease inhibitors.
   Google Scholar
• WANG QM, JOHNSON RB, COX GA, VILLARREAL EC, LON-CHARICH RJ: A continuous colorimetric assay for rhinovirus-14 3C protease using peptide p-nitroanilides as substrates. Anal. Biochem. (1997) 252:238–245.
   PubMed Web of Science ®Google Scholar
• •Substrate specificity studies of the 3C protease. The informa-tion provided in this paper is important for rational design of 3C protease inhibitors.
   Google Scholar
• KALDOR SW, HAMMOND M, DRESSMAN BA et al.: Glutamine-derived aldehydes for the inhibition of hu-man rhinovirus 3C protease. Bioorg. Med. Chem. Lett. (1995) 5:2021–2026.
   Google Scholar
• ••Synthesis and evaluation of peptidic aldehydes as HRV 3Cprotease inhibitors.
   Google Scholar
• MALCOLM BA, LOWE C, SHECHOSKY S et al: Peptide al- dehyde inhibitors of hepatitis A virus 3C proteinase. Biochemistry. (1995) 34:8172–8179.
   PubMedGoogle Scholar
• ••Synthesis and evaluation of peptidic aldehydes as hepatitisA virus and HRV 3C protease inhibitors.
   Google Scholar
• SHEPHERD TA, COX GA, MCKINNEY E et al.: Small pepti- dic aldehyde inhibitors of human rhinovirus 3C prote-ase. Bioorg. Med. Chem. Lett. (1996) 6:2893–2896.
   Google Scholar
• ••Synthesis and evaluation of dipeptidic aldehyde with PI me-thionine sulfone as 3C protease inhibitor.
   Google Scholar
• HANZLIK RP, THOMPSON SA: Vinylogous amino acid es-ters: a new class of inactivators for thiol proteases. Merl. Chem. (1984) 27:711–712.
   PubMedGoogle Scholar
• LIU S, HANZLIK RP: Structure-activity relationships forinhibition of papain by peptide Michael acceptors. J. Merl. Chem. (1992) 35:1067–1075.
   PubMed Web of Science ®Google Scholar
• KONG J, VENKATRAMAN S, FURNESS K et al.: Synthesis and evaluation of peptidyl Michael acceptors that inac-tivate human rhinovirus 3C protease and inhibit virus replication. J. Merl. Chem. (1998). (In Press).
   Google Scholar
• ••Peptidic Michael acceptors as 3C protease inhibitors.
   Google Scholar
• SHAM HL, ROSENBROOK W, KATI W et al.: Potent inhibi- tor of the human rhinovirus HRV 3C protease contain-ing a backbone modified glutamine. J. Chem. Soc. Perkin Trans. 1(1995) 1081–1082.
   Google Scholar
• ••Peptidic ketone as 3C enzyme inhibitor.
   Google Scholar
• WEBBER SE, TIKHE J, WORLAND ST et al.: Design, syn- thesis, and evaluation of nonpeptidic inhibitors of hu-man rhinovirus 3C protease. J. Merl. Chem. (1996) 39:5072–5082.
   PubMed Web of Science ®Google Scholar
• ••Synthesis and evaluation of isatins as 3C inhibitors.
   Google Scholar
• JUNGHEIM LN, COHEN JD, JOHNSON RB et al: Inhibition of human rhinovirus 3C protease by homophtha-limides. Bioorg. Merl. Chem. Lett. (1997) 7:1589–1594.
   Google Scholar
• ••Inhibition of HRV 3C and 2A protease by homophtha-limides.
   Google Scholar
• WANG QM, JOHNSON RB, JUNGHEIM LN, COHEN JD, VIL-LARREAL EC: Dual Inhibition of human rhinovirus 2A and 3C proteases by homophthalimides. Antimicro. Agents & Chemother. (1998) 42:916–920.
   PubMedGoogle Scholar
• ••Inhibition of HRV 3C and 2A protease by homophtha-limides.
   Google Scholar
• KORANT BD, TOWATARI T, IVANOFF L et al.: Viral ther-apy: prospects for protease inhibitors. J. Cell. Biochem. (1986) 32:91–95.
   PubMedGoogle Scholar
• WEBBER SE, OKANO K, LITTLE TL et al.: Tripeptide alde-hyde inhibitors of human rhinovirus 3C protease: the design, synthesis, biological evaluation and cocrystal structure solution of P1 glutamine isosteric replace-ments. J. Med. Chem. (1998) 41:2786–2805.
   PubMed Web of Science ®Google Scholar
• ••Tripeptide aldehyde inhibitors of HRV 3C protease.
   Google Scholar
• DRAGOVICH PS, WEBBER SE, BABINE RE et al.:Structure-based design, synthesis, and biological evaluation of irreversible human rhinovirus 3C prote-ase inhibitors. 1. Michael acceptor structure-activity studies. J. Med. Chem. (1998) 41:2806–2818.
   Google Scholar
• ••Synthesis and evaluation of peptidic Michael acceptors as 3Cprotease inhibitors.
   Google Scholar
• DRAGOVICH PS, WEBBER SE, BABINE RE et al.: Structure-based design, synthesis, and biological evaluation of irreversible human rhinovirus 3C prote-ase inhibitors. 2. Peptide structure-activity studies. J. Med. Chem. (1998) 41:2819–2834.
   Google Scholar
• ••Synthesis and evaluation of peptidic Michael acceptors as 3Cprotease inhibitors.
   Google Scholar